Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2002 | 09-2002 | 06-2002 | 03-2002 | 12-2001 | |
Sales | 4,548 | 4,822 | 4,593 | 4,531 | 5,198 |
Gross Profit | 4,550 | 4,820 | 4,590 | 5,370 | 5,220 |
Operating Expenses | 7,980 | 9,010 | 10,010 | 10,800 | 12,440 |
Operating Income | -3,432 | -4,188 | -5,417 | -6,269 | -7,242 |
Interest Expense | 440 | 420 | 300 | 260 | 220 |
Other Income | -2,228 | -222 | -713 | 129 | -618 |
Pre-tax Income | -6,100 | -4,830 | -6,430 | -6,400 | -8,080 |
Net Income Continuous | -6,090 | -4,834 | -6,437 | -6,406 | -8,070 |
Net Income | $-6,090 | $-4,834 | $-6,437 | $-6,406 | $-8,070 |
EPS Basic Total Ops | -8,403.36 | -7,703.08 | -10,504.20 | -10,504.20 | -13,305.32 |
EPS Basic Continuous Ops | -8,700.00 | -8,056.67 | -10,728.33 | -10,676.67 | -13,450.00 |
EPS Diluted Total Ops | -8,403.36 | -7,703.08 | -10,504.20 | -10,504.20 | -13,305.32 |
EPS Diluted Continuous Ops | -8,700.00 | -8,056.67 | -10,728.33 | -10,676.67 | -13,450.00 |
EBITDA(a) | $-2,622 | $-3,248 | $-4,517 | $-5,309 | $-4,922 |